ArticleFrontiers in oncology2024

Response to furmonertinib in a patient with non-small cell lung cancer harboring HER2 exon 21 insertion mutation: a case report.

Chunxiao Ni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.